Sie sind hier:
  • Home
  • > S3 Guidelines

New evidence-based S3 Guidelines for Alcohol and Tobacco Dependence published

Logo Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)

Alcohol and tobacco dependence belong to the most serious addictive disorders in Germany. Each year about 74.000 people die from the consequences of their alcohol abuse. About 110.000 cases of death have to be attributed to smoking. On February 3rd, 2015 two new treatment guidelines were presented in Berlin, which summarise the actual state of knowledge on diagnose and treatment of harmful and dependent alcohol and tobacco use.

The new guidelines were elaborated in a developmental process over 4 years within the scope of the Association of Scientific Medical Expert Societies (Arbeitsgemeinschaft Wissenschaftlich Medizinischer Fachgesellschaften (AWMF) and were headed by the German Society for Addiction Research and Addiction Therapy (DG-Sucht) as well as the German Society for Psychiatry, Psychotherapy, Psychosomatic and Neurology (DGPPN). More than 50 expert societies, professional associations, health service organisations, self-help and relatives’ groups and more than 60 renowned experts in the addiction field were involved in this process.

S3-guideline "Screening, Diagnose and Treatment of alcohol-related Disorders" (long version)
undefinedpdf

S3-guideline "Screening, diagnose and treatment of alcohol-associated disorders, table volume"
undefinedpdf

S3-guideline "Screening, diagnose and treatment of alcohol-related disorders, guideline report"
undefinedpdf

S3-guideline "Screening, Diagnose and treatment of harmful and dependent tobacco use (long version)
undefinedpdf

S3-guideline "Screening, diagnose and treatment of harmful and dependent tobacco use, guideline report"
undefinedpdf

S3-guideline "Screening, diagnose and treatment of harmful and dependent tobacco use, special chapter"
undefinedpdf

Further information:

Press text
undefinedpdf

Press text alcohol
undefinedpdf

Press text tobacco
undefinedpdf

Press text methodology
undefinedpdf

Contact

Prof. Karl Mann, MD (Scientific head alcohol)
Central Institute of Mental Health, Medical Faculty Mannheim,
University of Heidelberg
Email: Karl.Mann@zi-mannheim.de

Prof. Dr.  Anil Batra, MD (Scientific head tobacco)
Section for Addiction Medicine and Addiction Research, University Hospital for Psychiatry and Psychotherapy
Email: anil.batra@med.uni-tuebingen.de